Frédéric Van Gool
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Physiology top 1%
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 8
- Immunology 10
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 4
- IL-33, ST2, and ILC Pathways 3
- Toxin Mechanisms and Immunotoxins 2
- Co-authors
- Oberdan Léo (11 shared papers)Fabienne Andris (6 shared papers)Anthony Rongvaux (6 shared papers)Mara Gallí (7 shared papers)Jeffrey A. Bluestone (6 shared papers)Ari B. Molofsky (2 shared papers)Richard M. Locksley (2 shared papers)Hong-Erh Liang (2 shared papers)
- Journals
- The Journal of Immunology (2 papers)Biochemical Pharmacology (2 papers)Frontiers in Immunology (2 papers)Immunity (2 papers)PLoS ONE (2 papers)
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Frédéric Van Gool
19 papers receiving 2.3k citations
Frédéric Van Gool's Hit Papers
Peers
Comparison fields: 5 of 95
- Geriatrics and Gerontology 487
- Physiology 245
- Immunology 787
- Biological Psychiatry 77
- Aging 46
Countries citing papers authored by Frédéric Van Gool
This map shows the geographic impact of Frédéric Van Gool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Van Gool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Van Gool more than expected).
Fields of papers citing papers by Frédéric Van Gool
This network shows the impact of papers produced by Frédéric Van Gool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Van Gool. The network helps show where Frédéric Van Gool may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Van Gool, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 357 | |
| 2 | Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes Hit paper breakdown → | 2019 | 267 |
| 3 | 2018 | 244 | |
| 4 | 2003 | 240 | |
| 5 | 2009 | 232 | |
| 6 | 2008 | 209 | |
| 7 | 2008 | 152 | |
| 8 | 2009 | 122 | |
| 9 | 2021 | 91 | |
| 10 | 2014 | 87 | |
| 11 | 2011 | 85 | |
| 12 | 2019 | 75 | |
| 13 | 2010 | 45 | |
| 14 | 2015 | 37 | |
| 15 | 2019 | 23 | |
| 16 | 2006 | 17 | |
| 17 | 2020 | 12 | |
| 18 | 2007 | 1 | |
| 19 | 2009 | 1 |
About Frédéric Van Gool
Frédéric Van Gool is a scholar working on Oncology, Immunology, Geriatrics and Gerontology, Physiology and Surgery, having authored 19 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Sirtuins and Resveratrol in Medicine (8 papers), PARP inhibition in cancer therapy (8 papers), Calcium signaling and nucleotide metabolism (6 papers), T-cell and B-cell Immunology (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Diabetes and associated disorders (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Geriatrics and Gerontology (487 citations), Physiology (245 citations), Immunology (787 citations), Biological Psychiatry (77 citations) and Aging (46 citations). Frédéric Van Gool has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Oberdan Léo, Fabienne Andris, Anthony Rongvaux, Mara Gallí, Jeffrey A. Bluestone, Ari B. Molofsky, Richard M. Locksley, Hong-Erh Liang, Thibaut De Smedt and Steven J. Van Dyken. Their work appears in journals such as The Journal of Immunology, Biochemical Pharmacology, Frontiers in Immunology, Immunity and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.